BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sinclair M. Controversies in Diagnosing Sarcopenia in Cirrhosis-Moving from Research to Clinical Practice. Nutrients. 2019;11:2454. [PMID: 31615103 DOI: 10.3390/nu11102454] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
Number Citing Articles
1 Hou W, Wu J, Wang K, Wang Z, Wang Z, Chen F, Yu H, Meng Q. Sarcopenia is associated with reduced 5-year survival in cirrhotic patients with age ≥ 65 and Child-Pugh score ≥ 7.. [DOI: 10.21203/rs.3.rs-2251805/v1] [Reference Citation Analysis]
2 Quinlan JI, Jones C, Bissonnette E, Dhaliwal A, Williams F, Choudhary S, Breen L, Lavery GG, Armstrong MJ, Elsharkawy AM, Lord JM, Greig CA. The Impact of Slice Interval and Equation on the Accuracy of Magnetic Resonance Image Estimation of Quadriceps Muscle Volume in End Stage Liver Disease. Front Rehabilit Sci 2022;3. [DOI: 10.3389/fresc.2022.854041] [Reference Citation Analysis]
3 Anand A, Mohta S, Agarwal S, Sharma S, Gopi S, Gunjan D, Madhusudhan KS, Singh N, Saraya A. European Working Group on Sarcopenia in Older People (EWGSOP2) Criteria With Population-Based Skeletal Muscle Index Best Predicts Mortality in Asians With Cirrhosis. Journal of Clinical and Experimental Hepatology 2022;12:52-60. [DOI: 10.1016/j.jceh.2021.03.015] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
4 Javaid N, Iqbal AZ, Hameeda M. NUTRITIONAL MANAGEMENT OF LIVER CIRRHOSIS AND ITS COMPLICATIONS IN HOSPITALIZED PATIENTS. Arq Gastroenterol 2021;58:246-52. [PMID: 34287534 DOI: 10.1590/S0004-2803.202100000-43] [Reference Citation Analysis]
5 Hari A. Muscular abnormalities in liver cirrhosis. World J Gastroenterol 2021; 27(29): 4862-4878 [PMID: 34447231 DOI: 10.3748/wjg.v27.i29.4862] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
6 Lanthier N, Stärkel P, Dahlqvist G. Muscle mass depletion in chronic liver diseases: An accelerated model of aging or a distinct entity? Clin Res Hepatol Gastroenterol 2021;45:101721. [PMID: 34087426 DOI: 10.1016/j.clinre.2021.101721] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
7 West J, Gow PJ, Testro A, Chapman B, Sinclair M. Exercise physiology in cirrhosis and the potential benefits of exercise interventions: A review. J Gastroenterol Hepatol 2021. [PMID: 33638197 DOI: 10.1111/jgh.15474] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
8 Kamimura H, Sato T, Natsui K, Kobayashi T, Yoshida T, Kamimura K, Tsuchiya A, Murayama T, Yokoyama J, Kawai H, Takamura M, Terai S. Molecular Mechanisms and Treatment of Sarcopenia in Liver Disease: A Review of Current Knowledge. Int J Mol Sci 2021;22:1425. [PMID: 33572604 DOI: 10.3390/ijms22031425] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
9 Lee DU, Fan GH, Ahern RR, Karagozian R. The effect of malnutrition on the infectious outcomes of hospitalized patients with cirrhosis: analysis of the 2011–2017 hospital data. European Journal of Gastroenterology & Hepatology 2021;32:269-78. [DOI: 10.1097/meg.0000000000001991] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
10 Mikolasevic I, Pavic T, Kanizaj TF, Bender DV, Domislovic V, Krznaric Z. Nonalcoholic Fatty Liver Disease and Sarcopenia: Where Do We Stand? Can J Gastroenterol Hepatol 2020;2020:8859719. [PMID: 33204675 DOI: 10.1155/2020/8859719] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
11 Aguirre F, Abrigo J, Gonzalez F, Gonzalez A, Simon F, Cabello-Verrugio C. Protective Effect of Angiotensin 1-7 on Sarcopenia Induced by Chronic Liver Disease in Mice. Int J Mol Sci 2020;21:E3891. [PMID: 32485991 DOI: 10.3390/ijms21113891] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
12 Vidot H, Kline K, Cheng R, Finegan L, Lin A, Kempler E, Strasser SI, Bowen DG, McCaughan GW, Carey S, Allman-Farinelli M, Shackel NA. Reply to "Comments on the Editor Re: The Relationship of Obesity, Nutritional Status and Muscle Wasting in Patients Assessed for Liver Transplantation, Nutrients 2019, 11, 2097.". Nutrients 2020;12:E869. [PMID: 32213917 DOI: 10.3390/nu12030869] [Reference Citation Analysis]
13 Raman M, Tandon P, Merli M. Nutrition in Liver Cirrhosis and Transplantation—Current State and Knowledge Gaps. Nutrients 2020;12:680. [DOI: 10.3390/nu12030680] [Reference Citation Analysis]